A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 the 340B Drug Pricing Nondiscrimination Act.
A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 the 340B Drug Pricing Nondiscrimination Act.
Head-To-Head Analysis: Exelixis (NASDAQ:EXEL) vs JATT Acquisition (NYSE:JATT) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Exelixis (NASDAQ:EXEL – Get Free Report) and Editas Medicine (NASDAQ:EDIT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Analyst Recommendations This is a summary of recent ratings […]
Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) and Exelixis (NASDAQ:EXEL – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk. Valuation & Earnings This table compares Genocea Biosciences and […]